HeartBeam, Inc. (BEAT)
| Market Cap | 46.86M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -21.02M |
| Shares Out | 53.63M |
| EPS (ttm) | -0.62 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 708,898 |
| Open | 0.894 |
| Previous Close | 0.880 |
| Day's Range | 0.855 - 0.898 |
| 52-Week Range | 0.540 - 4.000 |
| Beta | -0.64 |
| Analysts | Strong Buy |
| Price Target | 5.63 (+544.31%) |
| Earnings Date | May 8, 2026 |
About BEAT
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart’s electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician port... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for BEAT stock is "Strong Buy." The 12-month stock price target is $5.63, which is an increase of 544.31% from the latest price.
News
HeartBeam Announces Closing of $10 Million Public Offering of Common Stock
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Closing of $10 Million Public Offering of Common Stock.
HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock.
HeartBeam Announces Proposed Public Offering of Common Stock
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Proposed Public Offering of Common Stock.
HeartBeam Reports Fourth Quarter and Full Year 2025 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Fourth Quarter and Full Year 2025 Results.
Heartbeam Stock Jumps After AI Collaboration With Mount Sinai
The collaboration will combine HeartBeam's patented ECG platform with Mount Sinai's artificial intelligence and clinical expertise to develop and validate advanced AI-ECG algorithms.
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home.
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch
SANTA CLARA--(BUSINESS WIRE)--HeartBeam to Attend Investor and Industry Conferences in March.
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study.
HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time.
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market.
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer.
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference.
Why Is Micro Cap HeartBeam Stock Surging On Wednesday?
HeartBeam, Inc.'s (NASDAQ: BEAT) stock is trading higher on Monday, with a session volume of 193.38 million compared to the average volume of 2.191 million as per data from Benzinga Pro.
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment.
HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application.
HeartBeam Reports Third Quarter 2025 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Third Quarter 2025 Results.
HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time.
HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere.
HeartBeam's Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam's Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias.
HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025.
HeartBeam Reports Second Quarter 2025 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Second Quarter 2025 Results.
HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time.
HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care with Groundbreaking ECG Technology.
HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025.
HeartBeam Reports First Quarter 2025 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports First Quarter 2025 Results.